Evidence for structural alterations in resistance arteries of patients with severe congestive heart failure

Journal of Vascular Research

Volumn 36, Issue 3, 1999, Pages 229-234

  Mengden, Th ^a   Douven, C ^a   Vetter, H ^a   Düsing, Rainer ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Congestive heart failure; Resistance vessels; Venous occlusion plethysmography

Indexed keywords

ADULT; AGED; ARTERY; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; VASCULAR RESISTANCE; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADULT; AGED; AGING; ARTERIES; BLOOD PRESSURE; FEMALE; FOREARM; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; VASCULAR RESISTANCE;

EID: 0032967521     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025646     Document Type: Article

References (27)

1. Franciosa JA, Park M, Levine TB: Lack of correlation between excercise capacity and indices of left ventricular performance in heart failure. Am J Cardiol 1981;47:33-39.
2. Franciosa JA, Leddy CL, Wilen M, Schartz DE: Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol 1984;53:127-134.
3. Cowley AJ, Fullwood LJ, Muller AF, Stainer K, Skene AM, Hampton JR: Exercise capability in heart failure: Is cardiac output important after all? Lancet 1991;337:771-773.
4. Mahy R, Tooke JE: Peripheral microvascular function in congestive heart failure. Clin Sci 1995;88:501-508.
5. Dzau V: Autocrine and paracrine mechanisms in the pathophysiology of heart failure. Am J Cardiol 1992;70:4C-11C.
6. Folkow B: Structural, myogenic, humoral and nervous factors controlling peripheral resistance; in Harrington M (ed): Hypotensive Drugs. London, Pergamon Press, 1956, pp 163-174.
7. Conway J: A vascular abnormality in hypertension: A study of blood flow in the forearm. Circulation 1963;27:520-529.
8. Braunwald E: Pathophysiology of heart failure; in Braunwald E (ed): Heart Disease. Philadelphia, Saunders, 1992, pp 393-418.
9. Sachinidis A, Ko Y, Nettekoven W, Wieczorek AJ, Düsing R, Vetter H: The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar-Kyoto rats. J Hypertens 1992; 10:1159-1164.
10. Takeshita A, Imaizumi T, Ashihara T, Yamamoto K, Hoka S, Nakamura M: Limited maximal vasodilatory capacity of forearm vascular resistance vessels in normotensive young men with a familial predisposition to hypertension. Circ Res 1982;50:671-677.
11. Egan B, Julius S: Vascular hypertrophy in borderline hypertension: Relationship to blood pressure and sympathetic drive. Clin Exp Hypertens 1985;7/2-3:243-255.
12. Sinoway LI, Musch TI, Minotti R, et al: Enhanced maximal metabolic vasodilation in the dominant forearms of tennis players. J Appl Physiol 1986;61:673-678.
13. Zelis R, Mason DT, Braunwald E: A comparison of the effect of vasodilator stimuli on peripheral resistance arteries in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-970.
14. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM: Endothelium-dependent vasodilation is attenuated in patients with severe heart failure. Circulation 1991;84:1589-1596.
15. Mulvany MJ: Resistance vessels in hypertension; in Swales J (ed): Textbook of Hypertension. Oxford, Blackwell, 1994, pp 103-109.
16. Korsgard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ: Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993;22:523-526.
17. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-481.
18. Schiffrin EL, Deng LY, Larochelle P: Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
19. Schmitz U, Ko Y, Becher H, Ludwig M, Vetter H, Düsing R: Evidence for cardiovascular remodelling in a patient with Bartter's syndrome. Clin Invest 1994;72:874-877.
20. Zelis R, Sinoway LI, Mush TI, Davis D, Just H: Regional blood flow in congestive heart failure: Concept of compensatory mechanisms with short and long time constants. Am J Cardiol 1988;62:2E-8E.
21. Longhurst J, Capone RJ, Zelis R: Evaluation of skeletal muscle capillary basement membrane thickness in congestive heart failure. Chest 1975;67:195-198.
22. LeJemtel TH, Maskin CS, Lucido D, Chadwick BJ: Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 1986;74:245-251.
23. Wroblewski H, Kastrup J, Nargard T, Mortensen S-A, Haunsø S: Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:769-774.
24. Stephens N, Drinkhill MJ, Hall AS, Ball SG, Heagerty AM: Structure and in vitro function of human subcutaneous small arteries in mild heart failure. Am J Physiol 1998;274:C1298-C1305.
25. Higginbotham MB, Morris KG, Conn EH, Coleman RE, Cobb FR: Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 1983;51:52-60.
26. Senni M, Rodeheffer RJ, Evans JM, Jacobsen SJ, Redfield MM: Diastolic heart failure in the community: A population-based study of incident cases of congestive heart failure in Olmsted County, Minnesota in 1991 (abstract). Circulation 1997;96/1:389.
27. Francis GS, Benedict C, Johnston DE, Kirlin PC, Nicklas J, Liang C, Kubo SH, Rudin-Toretsky E, Yusuf S: Comparison of neuroendocrine activation in patients with left ventricular dysfunction and with and without congestive heart failure. Circulation 1990;82:1724-1729.